Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter for Acute Ischemic Stroke
This study is testing a new device called the ANA Funnel Catheter for treating acute ischemic stroke (a type of stroke caused by a blood clot) in a procedure called mechanical thrombectomy. This procedure uses a stent retriever to remove blood clots. The ANA Funnel Catheter helps guide the stent retriever and can temporarily stop blood flow during the procedure, which may improve clot removal. Researchers want to see if the ANA Funnel Catheter is safe and effective compared to standard methods. They will measure how many patients achieve "near-complete" reperfusion (blood flow restored) after one attempt and the rate of serious bleeding in the brain. You may be eligible if you are between 22 and 85 years old and have experienced a recent stroke due to a large blood clot. The study's current status is unclear, and it aims to enroll 327 participants.
- Study design
- This is a randomized study comparing the ANA Funnel Catheter to conventional mechanical thrombectomy. It plans to enroll 327 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Safety will be assessed within 24 hours of the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
At a glance
Conditions
NCT06370182
Where you'd take part
This study runs at 22 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Advocate Health
Park Ridge, Illinoisstudy coordinator listed
Recruiting
Aydin University Hospital
Istanbul, Turkey (Türkiye)study coordinator listed
Recruiting
Baptist Health Medical Center
Jacksonville, Floridastudy coordinator listed
Recruiting
Boston Medical Center
Boston, Massachusettsstudy coordinator listed
Recruiting
Centre Hospitalier Universitaire de Montpellier
Montpellier, Francestudy coordinator listed
Recruiting
Centre Hospitalier Universitaire de Toulouse
Toulouse, Francestudy coordinator listed
Recruiting
Fondation Rothschild
Paris, Francestudy coordinator listed
Recruiting
Grady Memorial Hospital, Emory
Atlanta, Georgiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Adnan Siddiqui, MD, PhD, FAHA · PRINCIPAL_INVESTIGATOR · Jacobs School of Medicine & Biomedical Sciences
- Santiago Ortega-Gutierrez, MD, MSc, FAHA, FSVIN · PRINCIPAL_INVESTIGATOR · University of Iowa
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Proportion of subjects with "near-complete" reperfusion after one thrombectomy pass (FPE, eTICI 2c-3, extended Thrombolysis in Cerebral Infarction scale) in the target vessel.intra-operative
Reperfusion (eTICI 2c-3) to be assessed by an independent Core Lab.
- Rate of symptomatic intracranial hemorrhage (sICH), attributable to the device or procedure.Within 24 hours of the procedure
Extent of hemorrhage to be assessed by an independent Core Lab, symptoms to be assessed by the Data Monitoring Committee (DMC).